Three-Year Study Indicates Contact Lens Therapy Effective in Slowing Myopia Progression in Children

By Staff
Monday, June 19, 2017 12:15 AM LIVERPOOL, England —A new contact lens therapy has significant potential to address the rising prevalence of myopia (nearsightedness) in children, according to the results of study outcomes presented here at the British Contact Lens Association Clinical Conference, according to an announcement by CooperVision.

Updated: Connecticut Senate Approves Legislation That Sets Restrictions on CL Rx's Derived from Online Tests

By Staff
Wednesday, June 7, 2017 4:25 PM HARTFORD, Conn.—In the final hours of the 2017 legislative regular session, the Senate in Connecticut voted unanimously late Tuesday night to approve a bill that will limit the use of some new technologies in issuing or refilling prescriptions for contact lenses.

Coalition for Vision Safety Members Meet With FTC to Discuss Contact Lens Rule

By Staff
Friday, May 26, 2017 12:24 AM WASHINGTON—Several member companies of the Coalition for Patient Vision Safety participated in a meeting earlier this week with Federal Trade Commission (FTC) acting chairman Maureen Ohlhausen to discuss the FTC’s proposed changes to the Contact Lens Rule.

AOA and J&J Executives Advocate for Optometry and Patient Safety in Capitol Hill Meetings

By Staff
Friday, May 19, 2017 12:27 AM WASHINGTON, D.C.—Industry leaders visited Capitol Hill this week to deliver a message to Congress about eyecare, patient safety and the importance of “in-person vision care” provided by optometrists.

Valeant Reports First-Quarter Results and Raises Full-Year Adjusted Earnings Guidance Range

By Staff
Wednesday, May 10, 2017 12:26 AM LAVAL, Quebec—Valeant Pharmaceuticals International Inc. (NYSE: VRX) (TSX: VRX), parent company of Bausch + Lomb, reported Tuesday that divestiture efforts enabled the company to reduce its debt by $1.3 billion in the first quarter of 2017 and by $3.6 billion overall since the end of the first quarter of 2016.

Bausch + Lomb Names Gordon to Oversee U.S. Vision Care Business

By Staff
Friday, March 31, 2017 12:30 AM BRIDGEWATER, N.J.— Bausch + Lomb, a unit of Valeant Pharmaceuticals International, Thursday announced several changes to its U.S. management team that it said are "designed to improve operational efficiencies and foster potential synergies to drive growth."

Visioneering Technologies Successfully Lists on ASX

By Staff
Friday, March 31, 2017 12:23 AM ATLANTA—Visioneering Technologies (ASX:VTI), the maker of NaturalVue Multifocal 1 Day contact lenses, announced that it is now listed on the Australian Securities Exchange after raising $33.3 million following the close of its initial public offer.

CooperVision Revises Unilateral Pricing Policy (UPP) On Some Products

By Staff
Wednesday, March 29, 2017 12:33 AM PLEASANTON, Calif.— CooperVision, a unit of The Cooper Cos. (NYSE:COO), is the latest contact lens company to make changes to its Unilateral Pricing Policy (UPP).

Virginia Approves New Telemedicine Regulations for ‘Ophthalmic Prescriptions’

By Staff
Friday, March 10, 2017 12:33 AM RICHMOND, Va.—The state of Virginia in February approved legislation that amends the state code and clarifies and adds to the requirements for ophthalmic prescriptions, including via a telemedicine approach.

Start-up Hubble Gets Funding for Contact Lens Subscription Service

By Staff
Wednesday, March 8, 2017 12:23 AM NEW YORK—Hubble, an e-commerce company that offers a subscription service for its own brand of contact lenses, has raised a new round of $16.5 million in a Series A round of funding, which was supported by several venture capital groups.

The Cooper Companies Revenue Increases in First Quarter 2017

By Staff
Friday, March 3, 2017 12:26 AM PLEASANTON, Calif—The Cooper Companies (NYSE:COO) announced that revenue for the fiscal first quarter ended Jan. 31, 2017 increased 11 percent year-over-year to $499.1 million or 8 percent pro forma.

Johnson & Johnson Vision Is Created With Completion of J&J’s Acquisition of AMO

By Staff
Wednesday, March 1, 2017 12:24 AM NEW BRUNSWICK, N.J.— Johnson & Johnson (NYSE: JNJ) announced an updated organizational and leadership structure this week for what will now be known as Johnson & Johnson Vision (J&J Vision), effective with the completion of the acquisition this week of Abbott Medical Optics (AMO), a wholly-owned subsidiary of Abbott.

20 State AGs Among 4,000 ‘Commenters’ to FTC Over Proposed Changes to Contact Lens Rule

By Staff
Friday, February 24, 2017 12:30 AM WASHINGTON, D.C.—The comment period on the Federal Trade Commission’s proposed changes to the Contact Lens Rule ended Jan. 30 with more than 4,000 “commenters” submitting their views, including a comment in favor of FTC’s proposed changes that was signed by attorneys general of 20 states.

ABB Optical Group Publishes Year-in-Review Industry Insights

By Staff
Wednesday, February 22, 2017 12:24 AM CORAL SPRINGS, Fla.—Calendar year 2016 was notable for “consistent growth” and “strong sales” of contact lenses, particularly daily disposals, according to ABB Optical Group’s year-in-review report on the U.S. optical market.

EyeCare Prime Teams With Optometry Giving Sight to Launch LensFerry S Gives Sight Initiative

By Staff
Wednesday, February 22, 2017 12:18 AM PLEASANTON, Calif.—In support of its ongoing commitment to provide basic eyecare to underserved populations around the world, EyeCare Prime has partnered with Optometry Giving Sight to introduce its own philanthropic initiative, LensFerry S Gives Sight, according to an announcement from EyeCare Prime.
Loading...